Windlas Biotech Limited (WINDLAS) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE0H5O01029
Key metrics
- Market Cap
- ₹2,281 Cr
- P/E Ratio
- 32.62
- EPS
- 33.88
- Book Value
- 275.2
- P/B Ratio
- 4.02
- ROE
- 11.44%
- ROCE
- 12.05%
- Debt / Equity
- 0.06
- Net Margin
- 7.4%
- Revenue Growth
- 18.88%
- Profit Growth
- 8.95%
- Dividend Yield
- 0.62%
- 52W High
- ₹1,117.95
- 52W Low
- ₹697.40
- Market Cap Band
- small cap
- Face Value
- 5
Ratios computed from the annual results period ending 2026-03-31.
About Windlas Biotech Limited
Windlas Biotech Limited, a contract development and manufacturing organization, manufactures and trades in pharmaceutical products in India. The company offers contract manufacturing; customized formulations; contract research and manufacturing services; customized formulation; and regulatory services. It also manufactures tablets, capsules, oral solids, modified-release formulations, chewable and dispersible tablets, customized generics, and complex generics and multi-drug combinations, as well as injectables, including liquid vials, lyophilized vials, and ampoules. In addition, the company offers generic drugs for respiratory, anti-diabetic, gastroenterology, cardiovascular and multivitamin, neuro anti-psychotic, diabetic care, nutraceuticals, nutritional supplement, urology, pain management, and injectable therapies. It also exports generic medicines, health supplements, and custom-branded formulations. The company sells generic medicines, health supplements, and custom-branded formulations under Windlas brand names. Windlas Biotech Limited was incorporated in 2001 and is headquartered in Dehradun, India.
- Headquarters
- Dehradun, India
- Employees
- 1,385
- Promoter Holding
- 66.22%
The full Windlas Biotech Limited analysis
Create a free account to open the complete WINDLAS deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.